Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.

Clinical trial NCT05265234 · UNKNOWN

Trial details

NCT number: NCT05265234
Sponsor: OptiSkin Medical
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Eczema Atopic Dermatitis

Start date: 2022-03-01
Primary completion: 2023-03-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.